NCT03345082 · Interventional trial
A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD
Overall registry status Completed
Phase 2
Conditions Neovascular Age-related Macular Degeneration
Delaware Valley sites
- Opthea Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory